跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 99,283 条关于
“Motor Neurone Disease Association”
全部
99,283
临床试验
74,892
药物
1,513
机构
367
资讯
22,511
去年
£7.5 Million Longitude Prize Launches to Accelerate AI-Driven ALS Drug Discovery
4年前
Low-Dose Interleukin-2 Shows Promise in Slowing Motor Neurone Disease Progression in Landmark MIROCALS Trial
上个月
Trace Neuroscience Launches First-in-Human Trials of UNC13A-Targeting ASO for ALS, While EXPERTS-ALS Platform Demonstrates Rapid Drug Screening Capability
10个月前
Experimental Drug M102 Shows Promise in Slowing Motor Neurone Disease Progression
去年
Ellorarxine Shows Promise in Motor Neurone Disease Treatment by Targeting Neuroprotection, Neuroplasticity, and Neurorepair
去年
Tofersen Closer to Approval for SOD1-Related MND After NICE Reconsideration
去年
Tofersen Shows Promise in Slowing Progression of SOD1 Motor Neuron Disease
3年前
MIROCALS Trial Results: Low-Dose IL-2 Shows Potential Benefit for Subset of MND Patients
去年
Prasinezumab Shows Sustained Benefit in Parkinson's Disease Motor Progression
去年
NuNerve's NUN-004 Shows Promise in Phase 1 MND Clinical Trial
第 1 页，共 2252 页
上一页
下一页
